Skip to content
10-Q

Quarterly Report

REGEN BIOPHARMA, INC. RGBP RGBPP

0001641172-25-022884

← back to feed
Filed
Aug 11, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Net Income Q3 2025 · Sep 30, 2025 −$702.03K
Net Income Q3 2025 · Jun 30, 2025 −$167.29K
Net Income Q3 2025 · Jun 30, 2025 −$702.03K
Net Income Q3 2025 · Jun 30, 2024 −$130.12K
Net Income restated Q3 2025 · Jun 30, 2024 −$397.51K
Shares Diluted Q3 2025 · Jun 30, 2025 23.75M sh
Shares Diluted Q3 2025 · Jun 30, 2025 20.36M sh
Shares Diluted Q3 2025 · Jun 30, 2024 4.21M sh
Shares Diluted Q3 2025 · Jun 30, 2024 3.97M sh
Shares Outstanding Q3 2025 · Jun 30, 2025 31.55M sh
Operating Cash Flow Q3 2025 · Jun 30, 2025 −$223.59K
Operating Cash Flow restated Q3 2025 · Jun 30, 2024 −$544.25K
Stockholders Equity Q3 2025 · Jun 30, 2025 −$5.82M
Stockholders Equity Q3 2025 · Mar 31, 2025 −$5.7M
Stockholders Equity Q3 2025 · Sep 30, 2024 −$5.22M
Stockholders Equity restated Q3 2025 · Jun 30, 2024 −$5.16M
Stockholders Equity restated Q3 2025 · Mar 31, 2024 −$5.18M
Stockholders Equity restated Q3 2025 · Sep 30, 2023 −$5.1M
Current Liabilities Q3 2025 · Jun 30, 2025 $6.01M
Current Liabilities Q3 2025 · Sep 30, 2024 $5.38M
Total Liabilities Q3 2025 · Jun 30, 2025 $6.01M
Total Liabilities Q3 2025 · Sep 30, 2024 $5.38M
Current Assets Q3 2025 · Jun 30, 2025 $179.11K
Current Assets Q3 2025 · Sep 30, 2024 $143.35K
Total Assets Q3 2025 · Jun 30, 2025 $196.84K
Total Assets Q3 2025 · Sep 30, 2024 $161.08K
Eps Diluted Q3 2025 · Jun 30, 2025 −$0.01
Eps Diluted Q3 2025 · Jun 30, 2025 −$0.03
Eps Diluted Q3 2025 · Jun 30, 2024 −$0.03
Eps Diluted restated Q3 2025 · Jun 30, 2024 −$0.10
Eps Basic Q3 2025 · Jun 30, 2025 −$0.01
Eps Basic Q3 2025 · Jun 30, 2025 −$0.03
Eps Basic Q3 2025 · Jun 30, 2024 −$0.03
Eps Basic restated Q3 2025 · Jun 30, 2024 −$0.10
Operating Income Q3 2025 · Jun 30, 2025 −$40.76K
Operating Income Q3 2025 · Jun 30, 2025 −$215.49K
Operating Income Q3 2025 · Jun 30, 2024 −$107.97K
Operating Income Q3 2025 · Jun 30, 2024 −$331.82K
Revenue Q3 2025 · Jun 30, 2025 $59.07K
Revenue Q3 2025 · Jun 30, 2025 $177.2K
Revenue restated Q3 2025 · Jun 30, 2024 $59.07K
Revenue restated Q3 2025 · Jun 30, 2024 $177.19K
Rd Expense Q3 2025 · Jun 30, 2024 $32.5K
Rd Expense Q3 2025 · Jun 30, 2024 $120.16K